You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API pasireotide

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing pasireotide

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	SIGNIFOR	pasireotide	0078-0633	MANNITOL	2026-12-14
Novartis Pharmaceuticals Corporation	SIGNIFOR	pasireotide	0078-0633	SODIUM HYDROXIDE	2026-12-14
Novartis Pharmaceuticals Corporation	SIGNIFOR	pasireotide	0078-0633	TARTARIC ACID	2026-12-14
Novartis Pharmaceuticals Corporation	SIGNIFOR	pasireotide	0078-0633	WATER	2026-12-14
Recordati Rare Diseases Inc	SIGNIFOR	pasireotide	55292-131	MANNITOL	2026-12-14
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for pasireotide

Excipient focus: MANNITOL

pasireotide drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pasireotide	0078-0633
Recordati Rare Diseases Inc	pasireotide	55292-131
>Company	>Ingredient	>NDC

pasireotide drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

pasireotide drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pasireotide	0078-0633
Recordati Rare Diseases Inc	pasireotide	55292-131
>Company	>Ingredient	>NDC

pasireotide drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TARTARIC ACID

pasireotide drug variants containing TARTARIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pasireotide	0078-0633
Recordati Rare Diseases Inc	pasireotide	55292-131
>Company	>Ingredient	>NDC

pasireotide drug variants not containing TARTARIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

pasireotide drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	pasireotide	0078-0633
Recordati Rare Diseases Inc	pasireotide	55292-131
>Company	>Ingredient	>NDC

pasireotide drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.